Heron疗法 HRTX 深 沪
已收盘 07-02 16:00:00 美东时间
0.4384
+0.014
+3.30%
华盛通- 最 高0.4495
- 今 开0.44
- 成交量 306.50万股
- 最 低 0.4195
- 昨 收 0.4244
- 总市值 8298.01万
- 52周最高 2.19
- 市盈率 静 --
- 换手率 1.62%
- 52周最低 0.382
- 委 比 -69.54%
- 总股本 1.89亿
- 历史最高 42.90
- 量 比 0.86
- 振 幅 7.07%
- 历史最低 0.16
- 每 手 1
- 风险率 0.38%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 火爆！24家大行集体上调派拓网络目标价，最高370美元；大摩上调美光目标价从520美元升至1050美元
火爆！24家大行集体上调派拓网络目标价，最高370美元；大摩上调美光目标价从520美元升至1050美元；犹他美容(ULTA)惨遭12家大行下调目标价>>
06-04 11:36
Needham Downgrades Heron Therapeutics to Hold
Needham analyst Serge Belanger downgrades Heron Therapeutics (NASDAQ:HRTX) from Buy to Hold.
06-03 18:16
Heron Therapeutics To Appeal Delaware Court Ruling Invalidating Two CINVANTI Patents In Litigation With Azurity
Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the U.S. District Court for the District of Delaware issued a decision in the patent
06-02 20:21
Heron Therapeutics shares are trading lower after the company reported worse-than-expected Q1 financial results.
Heron Therapeutics shares are trading lower after the company reported worse-th...
05-11 20:56
Earnings Scheduled For May 11, 2026
Companies Reporting Before The Bell • United Parks & Resorts (NYSE:PRKS) is...
05-11 19:11
新浪财经ESG：Heron Therapeutics Inc. MSCI（明晟）ESG评级调升至BB
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:22
期权扫描 | 绩前踏入“5000亿美元俱乐部”，美光获一Call单押注续升至500美元；SoFi期权成交活跃，连续两日登榜TOP10
绩前踏入“5000亿美元俱乐部”，美光获一Call单押注续升至500美元；遭浑水做空！SoFi期权成交活跃，连续两日登榜TOP10；微软看跌期权连日攀升至超六成>>
03-18 19:20
Heron Therapeutics shares are trading higher after the company reported better-than-expected Q4 sales results and issued FY26 sale guidance above estimates.
Heron Therapeutics shares are trading higher after the company reported better-...
02-27 01:34
Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
Heron Therapeutics Inc. to Report Q4 and Full Year 2025 Results
Heron Therapeutics Inc. to Report Q4 and Full Year 2025 Results Heron Therapeutics Inc. will report its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026. The company will host a conference call and live webcast at 8:30 a.m. ET to discuss the results and recent busin
02-17 21:30
